Background: Orthostatic hypotension (OH) is the key manifestation of autonomic dysfunction with many causes. Systemic neurological causes such as paraneoplastic syndrome are usually ignored. Methods: We retrospectively analyzed clinical and examination data of 2 patients who were hospitalized, with onset symptom of OH and who were diagnosed as paraneoplastic syndrome. Results: The patients were characteristic of an initial symptom of OH, positive anti-Hu antibody and albuminocytologic dissociation in the cerebrospinal fluid. Patient 2 died and Patient 1 worsened during follow-up. Conclusions: The diagnosis of paraneoplastic syndrome is usually neglected when the onset symptoms are autonomic dysfunctions such as OH. Neurologists should improve their knowledge to diagnose accurately.

Keywords:
Orthostatic hypotension, Paraneoplastic syndrome, Autonomic dysfunction, Albuminocytologic dissociation
1.
Angelousi A, Girerd N, Benetos A, Frimat L, Gautier S, Weryha G, BoivinM: Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis. J Hypertens 2014; 32: 1562–1571.
2.
Ricci F, De Caterina R, Fedorowski A: Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment. J Am Coll Cardiol 2015; 66: 848–860.
3.
Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martín A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG; ESC Scientific Document Group: 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018; 39: 1883–1948.
4.
Kaufmann H: Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 1996; 6: 125–126.
5.
Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS), Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W: Guidelines for the diagnosis and management of syncope. Eur Heart J 2009; 30: 2631–2671.
6.
Fedorowski A, Burri P, Melander O: Orthostatic hypotension in genetically related hypertensive and normotensive individuals. J Hypertens 2009; 27: 976–982.
7.
Freeman R: Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med 2008; 358: 615–624.
8.
Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 2008; 7: 327–340.
9.
Lorusso L, Hart IK, Ferrari D, Ngonga GK, Gasparetto C, Ricevuti G: Autonomic paraneoplastic neurological syndromes. Autoimmun Rev 2007; 6: 162–168.
10.
Lucchinetti CF, Kimmel DW, Lennon VA: Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998; 50: 652–657.
11.
Izumi Y, Masuda T, Horimasu Y, Nakashima T, Miyamoto S, Iwamoto H, Fujitaka K, Hamada H, Hattori N: Chronic intestinal pseudo-obstruction and orthostatic hypotension associated with small cell lung cancer that improved with tumor reduction after chemoradiotherapy. Intern Med 2017; 56: 2627–2631.
12.
Ricigliano VAG, Fossati B, Saraceno L, Cavalli M, Bazzigaluppi E, Meola G: MSA mimic? Rare occurrence of anti-hu autonomic failure and thymoma in a patient with parkinsonism: Case report and literature review. Front Neurosci 2018.12: 17.
13.
Neal AJ, Qian MY, Clinch AS, Le BH: Orthostatic hypotension secondary to crmp-5 paraneoplastic autonomic neuropathy. J Clin Neurosci 2014.21: 885–886.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.